Rapid COVID-19 tests at Indiana state and local health department testing sites will only be available to individuals aged 18 and younger and symptomatic individuals aged 50 and older, according to new guidelines issued by the Department of Health Jan. 4.
Following the end of a three-month agreement with the federal government to sell at-home COVID-19 tests at a lower price, Walmart and Kroger have raised the prices of Abbott Laboratories’ BinaxNow testing kits, NBC News reported Jan. 4.
Columbia, S.C.-based Rhino Medical Supply is now selling at-home COVID-19 tests to the public as cases surge in the state, Fox affiliate WACH reported Jan. 4.
Chicago-based medical technology company Hillrom is being sued by Linet, a global supplier of hospital beds, for allegedly using “anti-competitive” practices to slow the supplier’s growth in the U.S., the Chicago Tribune reported Dec. 29.
Florida Gov. Ron DeSantis is urging the federal government to allow states to buy monoclonal antibody treatments amid the latest COVID-19 surge, The Hill reported Jan. 3.
The Tennessee Department of Health has received a limited supply of the Merck and Pfizer oral antiviral treatments for COVID-19.
Here are eight supply chain updates from the past week:
Health systems across the nation are reporting shortages in sotrovimab, which The New York Times reported is the only COVID-19 monoclonal antibody treatment that appears to be effective against the omicron variant.
Ten health systems have posted job listings for supply chain expertise in the last week:
Rapid antigen tests may have reduced sensitivity in detecting the omicron COVID-19 variant, the FDA said in a Dec. 28 update.
